Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL Amyloidosis

Chuy, Katherine Lee; Drill, Esther; Yang, Ji Can; Landau, Heather; Hassoun, Hani; Nahhas, Omar; Chen, Carol L.; Yu, Anthony F.; Steingart, Richard M.; Liu, Jennifer E.

doi:10.1016/j.jaccao.2020.05.012

Cited by 36 publications

(24 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…801 Additionally, GLS ≥ −15% may serve as an independent prognostic factor of poor overall survival in patients with AL-CA. 802 CMR with LGE and parametric imaging has emerged as a new non-invasive gold-standard for diagnosis (Figure 43). 803,804 Nuclear scintigraphy can differentiate transthyretin amyloidosis from AL-CA supported by the presence of monoclonal protein.…”

Section: Amyloid Light-chain Cardiac Amyloidosismentioning

confidence: 99%

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Lyon¹,

López‐Fernández²,

Couch³

et al. 2022

European Heart Journal

1,116

934

View full text Add to dashboard Cite

Coronary care unit CDK Cyclin-dependent kinase CHA 2 DS 2 -VASc Congestive heart failure, Hypertension, Age ≥ 75 years (2 points), Diabetes mellitus, Stroke (2 points)-Vascular disease, Age 65-74 years, Sex category (female) CIED Cardiac implantable electronic device CML Chronic myeloid leukaemia CMR Cardiac magnetic resonance COMPASS-CAT Prospective COmparison of Methods for thromboembolic risk assessment with clinical Perceptions and AwareneSS in real-life patients-Cancer Associated Thrombosis CPET Cardiopulmonary exercise testing CrCl Creatinine clearance CRF Cardiorespiratory fitness CRS Cytokine release syndrome CS Cancer survivors CT Computed tomography CTLA-4 Cytotoxic T lymphocyte-associated antigen-4 cTn Cardiac troponin CTRCD Cancer therapy-related cardiac dysfunction CTR-CVT Cancer therapy-related cardiovascular toxicity CV Cardiovascular CVD Cardiovascular disease CVRF Cardiovascular risk factorsData derived from a single randomized clinical trial or large non-randomized studies.Consensus of opinion of the experts and/or small studies, retrospective studies, registries.©ESC 2022 ESC Guidelines © ESC 2022This table refers to anthracycline equivalence dose using doxorubicin as a reference. Note that these isoequivalent doses are derived from paediatric CS. CS, cancer survivors; CV, cardiovascular.a Data for idarubicin are based upon an estimated anticancer efficacy ratio, not derived from cardiotoxicity data. The CV toxicity dose ratio provides the value that should be used to multiply the dose of the anthracycline of interest to convert to isoequivalent doses of doxorubicin; e.g. to convert 125 mg/m 2 of epirubicin to doxorubicin isoequivalent, multiply the dose by 0.8 (125 mg/m 2 × 0.8 = 100 mg/m 2 of doxorubicin).

show abstract

Section: Amyloid Light-chain Cardiac Amyloidosismentioning

confidence: 99%

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Lyon¹,

López‐Fernández²,

Couch³

et al. 2022

European Heart Journal

1,116

934

View full text Add to dashboard Cite

show abstract

“…In one study on patients in advanced disease stages, stroke volume was superior even to strain. 9 This is not surprising if we consider that a fixed stroke volume indicates an advanced restrictive cardiomyopathy, with cardiac output relying mostly on heart rate. 4 , 5 Overall, the characterization of LV strain in AL-CA cannot ignore the assessment of its diagnostic and prognostic value during the different stages of the natural history of this condition.…”

Section: Why Has Ls Become So Important To Characterize Cardiac Involvement In Patients With Amyloidosis? What Is the Added Value Of Ls Bmentioning

confidence: 99%

“…2 The same observation had already been reported in at least two other studies. 8 , 9 Conversely, LVEF was reported to be a poor parameter to diagnose AL-CA, being reduced only in late disease stages. 10 LVEF was also a worse predictor of outcome than the myocardial contraction fraction (MCF), defined as the ratio between stroke volume and myocardial volume, reflecting the characteristic discrepancy between LV mass and contractility in CA.…”

Section: Why Has Ls Become So Important To Characterize Cardiac Involvement In Patients With Amyloidosis? What Is the Added Value Of Ls Bmentioning

confidence: 99%

Longitudinal strain in the management of cardiac AL amyloidosis: do we need it?

Rapezzi

Aimo

Pavasini

2021

European Heart Journal

View full text Add to dashboard Cite

“…Improving endurance is an important goal for treatment and prevention. Resilience is a structure based on the approach based on strengths and indicates the ability of people to cope with problems and risks [9]. In other words, resilience positively adapts to adverse conditions [10].…”

Section: Introductionmentioning

confidence: 99%

Investigating the predictive contribution of attitude towards life and belief system on self-resilience and psychological toughness of cancer patients about the mediating role of emotion regulation

Ghorbani

Asadi

Ghorbani

et al. 2023

2023 IEEE 21st World Symposium on Applied Machine Intelligence and Informatics (SAMI)

View full text Add to dashboard Cite

The purpose of the present study was to investigate the predictive contribution of attitude to life and belief system on self-resilience and psychological toughness of cancer patients about the mediating role of emotion regulation. The current research is fundamental in terms of its purpose and descriptive of correlation type in terms of method. The statistical population consists of all cancer patients of Shahinshahr city. The sample size was 150 people based on Cochran's formula and the country's corona situation. The sampling method of the current research is available. This research used tools of attitude to life, belief system, self-resilience, psychological toughness, and emotion regulation, all of which had acceptable reliability and validity. The research data was done in two parts, descriptive and inferential, with the help of Excel, SPSS, and SmartPLS software. The results showed that the attitude towards life and the belief system with the role of mediating emotion regulation has a significant predictive ability on the self-resilience of cancer patients. Also, attitude towards life and belief systems with the role of mediating emotion regulation can predict the psychological toughness of cancer patients. In addition, emotional regulation has a significant relationship with self-resilience and psychological toughness. According to the research results, it can be concluded that the attitude towards life and the belief system mediating emotion regulation can predict cancer patients' resilience and psychological toughness. Also, the attitude toward life and the belief system directly impacts. In addition, attitude towards life has a direct positive relationship with psychological toughness.

show abstract

Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL Amyloidosis

Cited by 36 publications

References 25 publications

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Longitudinal strain in the management of cardiac AL amyloidosis: do we need it?

Investigating the predictive contribution of attitude towards life and belief system on self-resilience and psychological toughness of cancer patients about the mediating role of emotion regulation

Contact Info

Product

Resources

About